Health

Datasea Announces Pricing of $2.0 Million Underwritten Public Offering

BEIJING, Sept. 12, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina, today announced the pricing ...

2023-09-12 20:30 4073

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

News Summary: * Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. * New pre-developed LC-MS analytical workflow...

2023-09-12 20:00 1426

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...

2023-09-12 20:00 958

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration

CASTRES, France and BASEL, Switzerland, Sept. 12, 2023 /PRNewswire/ --  Pierre Fabre Laboratories , the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer of novel cancer therapies. This first acquisition of...

2023-09-12 20:00 1231

Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers

Metabolon's new Biological Stress Discovery Panel supports inflammation, immune function, and stress research with advanced analytics  MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, di...

2023-09-12 19:57 1024

Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA

* HANSIZHUANG's coverage footprint includes 22 emerging market countries acrossSoutheast Asia and MENA – * KGbio to develop and commercialise HANSIZHUANG in 12 MENA countries; Henlius to receiveUS$7 million upfront payment plus royalties and up to US$8 million in regulatory milestone payments...

2023-09-12 19:24 1217

The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia

- Through the study "Elucidation of Mechanisms for Dementia Prevention and Improvement by Red Ginseng" SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Through continuous research, the secrets of ginseng, a representative medicinal herb of Korea, are being revealed, showcasing its efficacy. Re...

2023-09-12 17:00 1608

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagno...

2023-09-12 13:03 1714

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Melinda French Gates and Bill Gates call for urgent action to advance progress on the UN's Sustainable Development Goals and shine a spotlight on reducing maternal and child mortality SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Go...

2023-09-12 12:01 1495

When is it too late for a 'fairy tale ending' for women electing to freeze their oocytes?

ADELAIDE, Australia, Sept. 12, 2023 /PRNewswire/ -- Around the world, soaring numbers of women are electing to freeze their eggs to preserve their fertility, and many do so in anticipation of a "fairy tale ending" with the birth of a healthy baby. However, a reality check is needed to manage t...

2023-09-12 09:28 1381

Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures

SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully obtained approval from theChina's National Medical Products Administration (NMPA) for market release. The newly...

2023-09-12 07:00 1190

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...

2023-09-11 21:00 1522

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

SHENZHEN, China, Sept. 11, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research. Under the initiative, ...

2023-09-11 19:43 1011

IPMG Drives Health Transformation and Strengthens Indonesia's Economy Through Efforts to Accelerate Access to Innovative Medicines and Vaccines, also Partnerships

JAKARTA,  Indonesia, Sept. 11, 2023 /PRNewswire/ -- The research and development-based multinational pharmaceutical industry association, the International Pharmaceutical Manufacturers Group (IPMG) is always committed to supporting and encouraging advocacy and transformation of Government policie...

2023-09-11 18:52 1777

KT&G and the Indonesian Ministry of Investment jointly conduct investment support ceremony for KT&G's new manufacturing plant construction in Indonesia

* The new manufacturing plant is expected to commence production in 2026…expected to serve as an export hub SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- KT&G Corporation ("KT&G") (KRX:033780) conducted an investment support ceremony with the Indonesian Ministry of Investment and obtained ...

2023-09-11 17:29 4324

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 1095

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 1028

Can we really make a difference in reducing the heartbreak of millions of miscarriages each year?

ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Globally, one in six pregnancies end in miscarriage, which is generally defined as the loss of an intrauterine pregnancy before viability. This equates to an estimated 23 million miscarriages every year, or over 40 miscarriages per minute. Th...

2023-09-11 14:58 1278

Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors

SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for Phase I/II clinical trial ofBRL03 for the treatment of lung cancer, gastric cancer and other ad...

2023-09-11 14:53 1118

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical ...

2023-09-11 12:05 1837
1 ... 88899091929394 ... 813

Week's Top Stories